Floatz logo

Allogeneic Bone Marrow-Derived Mscs

Lumbar Disk Degenerative Disorder

University Hospital, MontpellierCell therapyPhase 2/3Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Lumbar Disk Degenerative Disorder cohort.

Asset / SponsorPhaseRating
NEPENTHE
Brigham and Women's Hospital
Phase 4BB
Oxycodone
Brigham and Women's Hospital
Phase 4BB
Pentoxifylline
St Joseph University, Beirut, Lebanon
Phase 4BB
IBUPROFEN
St Joseph University, Beirut, Lebanon
Phase 4BB
Rexlemestrocel-L
Mesoblast, Ltd.
Phase 3BB

View all 15 →

Same molecule, other indications

Allogeneic Bone Marrow-Derived Mscs is also rated in:

bone marrow failure syndromeDormant
CCC
Indicative ·
48 / 100
View asset →
bipolar depressionDormant
CC
Indicative ·
43 / 100
View asset →
Platinum-Resistant Fallopian Tube CarcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →